Cargando…

Editorial: Targeted Subcellular Delivery of Anti-cancer Agents

Detalles Bibliográficos
Autores principales:	Jans, David A., Sobolev, Alexander S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349720/ https://www.ncbi.nlm.nih.gov/pubmed/30723414 http://dx.doi.org/10.3389/fphar.2018.01577

Ejemplares similares

Editorial: Delivery of Locally-Acting Agents to Intracellular Targets
por: Rosenkranz, Andrey A., et al.
Publicado: (2020)

Modular Nanotransporters for Nuclear-Targeted Delivery of Auger Electron Emitters
por: Sobolev, Alexander S.
Publicado: (2018)

Editorial: Lymphatic delivery and targeting of drugs, vaccines, and imaging agents
por: Han, Sifei, et al.
Publicado: (2022)

Subcellular Targeting of Theranostic Radionuclides
por: Bavelaar, Bas M., et al.
Publicado: (2018)

Targeted Delivery of (111)In Into the Nuclei of EGFR Overexpressing Cells via Modular Nanotransporters With Anti-EGFR Affibody
por: Karyagina, Tatiana S., et al.
Publicado: (2020)

Targeted Intracellular Delivery of Antibodies: The State of the Art
por: Slastnikova, Tatiana A., et al.
Publicado: (2018)

Editorial: Protein-based nanocarriers for delivery of nutraceutical, diagnostic and therapeutic agents
por: Zhong, Jian, et al.
Publicado: (2022)

Editorial: Inspired by Nature: Towards Novel Anti-Infective Agents
por: Ferreira, Ricardo J., et al.
Publicado: (2022)

Membrane Trafficking and Subcellular Drug Targeting Pathways
por: Kumar, Ajay, et al.
Publicado: (2020)

Cell- and subcellular organelle-targeting nanoparticle-mediated breast cancer therapy
por: Wei, Xue, et al.
Publicado: (2023)

Editorial: Stem Cells as Targeted Drug Delivery Vehicles
por: Kusuma, Gina D., et al.
Publicado: (2020)

Delivery of Antioxidant and Anti-inflammatory Agents for Tissue Engineered Vascular Grafts
por: Washington, Kenyatta S., et al.
Publicado: (2017)

Editorial: Matricellular Receptors As Potential Targets in Anti-Cancer Therapeutic Strategies
por: Emonard, Hervé, et al.
Publicado: (2016)

Editorial: Anti-cancer effects of botanical drugs targeting the tumor microenvironment
por: Cheng, Chien-shan, et al.
Publicado: (2023)

Application of Mesenchymal Stem Cells for Therapeutic Agent Delivery in Anti-tumor Treatment
por: Chulpanova, Daria S., et al.
Publicado: (2018)

Editorial: Anti-Inflammatory Agents in the Context of Age-Related Cardiometabolic Disease: Ethnopharmacological Perspectives
por: Arumugam, Somasundaram, et al.
Publicado: (2022)

Editorial: The developments of metal-based agents against lung cancer
por: Gou, Yi, et al.
Publicado: (2022)

Editorial: Targeted Immunotherapy for Cancer
por: Williams, Williams V.
Publicado: (2022)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023)

Targeting potassium channels for increasing delivery of imaging agents and therapeutics to brain tumors
por: Khaitan, Divya, et al.
Publicado: (2013)

Advances and Challenges in Intranasal Delivery of Antipsychotic Agents Targeting the Central Nervous System
por: Pandey, Manisha, et al.
Publicado: (2022)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent
por: Trivedi, Vijay Laxmi, et al.
Publicado: (2023)

The Delivery of Biologically Active Agents into the Nuclei of Target Cells for the Purposes of Translational Medicine
por: Sobolev, A. S.
Publicado: (2020)

Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2016)

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy
por: Zhang, Chunxue, et al.
Publicado: (2023)

Editorial: Immunity in the development of anti-cancer drug resistance
por: Meng, Ya, et al.
Publicado: (2022)

Editorial: Women in pharmacology of anti-cancer drugs: 2021
por: Giovannetti, Elisa
Publicado: (2022)

Editorial: Insights in pharmacology of anti‐cancer drugs: 2021
por: Sancho, Patricia, et al.
Publicado: (2022)

Editorial: Medicinal Plants and Marine-Derived Natural Products as Cancer Chemopreventive Agents
por: Ullah, Riaz, et al.
Publicado: (2022)

Editorial: Intranasal Drug Delivery: Challenges and Opportunities
por: Fortuna, Ana, et al.
Publicado: (2022)

Editorial: Molecular imaging for tracking drug delivery
por: Han, Zheng, et al.
Publicado: (2023)

Editorial: Therapeutic targeting of splicing variants in cancer
por: Sarvari, Pouya, et al.
Publicado: (2023)

Editorial: Anti-cancer effects of natural products against reproductive cancers
por: Ribeiro, Rosy Iara Maciel Azambuja, et al.
Publicado: (2023)

Editorial: Bone targeting nanoparticle drug delivery system in bone metabolism and bone-related tumor diseases
por: Wang, Xing, et al.
Publicado: (2022)

Editorial: Recent trends and spotlight on nucleotide-based drugs: novel targets, their design, delivery, and clinical potential
por: Chander, Subhash, et al.
Publicado: (2023)

Corrigendum: Preclinical and Clinical Assessment of Cannabinoids as Anti-Cancer Agents
por: Ladin, Daniel A., et al.
Publicado: (2021)

Editorial: Model-Based Evaluation of Antimicrobial Agents in Children
por: Zhao, Wei, et al.
Publicado: (2021)

Editorial: Anti-cancer bioactive molecules from microbial sources
por: Mishra, Bishwambhar, et al.
Publicado: (2023)

Editorial: Emerging talents in pharmacology of anti-cancer drugs 2022
por: Khan, Husain Yar, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_blsgcfq2smarm69cgkdmtgc8sr